254 related articles for article (PubMed ID: 15761112)
21. Rapid regulation of the dopamine transporter: role in stimulant addiction?
Zahniser NR; Sorkin A
Neuropharmacology; 2004; 47 Suppl 1():80-91. PubMed ID: 15464127
[TBL] [Abstract][Full Text] [Related]
22. Dual dopamine-5-HT releasers: potential treatment agents for cocaine addiction.
Rothman RB; Blough BE; Baumann MH
Trends Pharmacol Sci; 2006 Dec; 27(12):612-8. PubMed ID: 17056126
[TBL] [Abstract][Full Text] [Related]
23. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
[TBL] [Abstract][Full Text] [Related]
24. In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys.
Wilcox KM; Kimmel HL; Lindsey KP; Votaw JR; Goodman MM; Howell LL
Synapse; 2005 Dec; 58(4):220-8. PubMed ID: 16206183
[TBL] [Abstract][Full Text] [Related]
25. Role of the increased noradrenergic neurotransmission in drug self-administration.
Wee S; Wang Z; He R; Zhou J; Kozikowski AP; Woolverton WL
Drug Alcohol Depend; 2006 Apr; 82(2):151-7. PubMed ID: 16213110
[TBL] [Abstract][Full Text] [Related]
26. Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.
Banks ML; Bauer CT; Blough BE; Rothman RB; Partilla JS; Baumann MH; Negus SS
Exp Clin Psychopharmacol; 2014 Jun; 22(3):274-284. PubMed ID: 24796848
[TBL] [Abstract][Full Text] [Related]
27. Reinforcing strength of a novel dopamine transporter ligand: pharmacodynamic and pharmacokinetic mechanisms.
Woolverton WL; Ranaldi R; Wang Z; Ordway GA; Paul IA; Petukhov P; Kozikowski A
J Pharmacol Exp Ther; 2002 Oct; 303(1):211-7. PubMed ID: 12235253
[TBL] [Abstract][Full Text] [Related]
28. Relationship between injection duration, transporter occupancy and reinforcing strength of cocaine.
Woolverton WL; Wang Z
Eur J Pharmacol; 2004 Feb; 486(3):251-7. PubMed ID: 14985046
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
[TBL] [Abstract][Full Text] [Related]
30. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
Katz JL; Kopajtic TA; Agoston GE; Newman AH
J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
[TBL] [Abstract][Full Text] [Related]
31. Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys.
Kohut SJ; Jacobs DS; Rothman RB; Partilla JS; Bergman J; Blough BE
Psychopharmacology (Berl); 2017 Dec; 234(23-24):3455-3465. PubMed ID: 28889212
[TBL] [Abstract][Full Text] [Related]
32. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
[TBL] [Abstract][Full Text] [Related]
33. Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat.
Cook CD; Carroll IF; Beardsley PM
Psychopharmacology (Berl); 2001 Dec; 159(1):58-63. PubMed ID: 11797070
[TBL] [Abstract][Full Text] [Related]
34. Dopaminergic and serotonergic autoreceptor stimulation effects are equivalent and additive in the suppression of spontaneous and cocaine induced locomotor activity.
Carey RJ; DePalma G; Damianopoulos E; Hopkins A; Shanahan A; Müller CP; Huston JP
Brain Res; 2004 Sep; 1019(1-2):134-43. PubMed ID: 15306247
[TBL] [Abstract][Full Text] [Related]
35. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
[TBL] [Abstract][Full Text] [Related]
36. Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic--A focus on analogues of benztropine and rimcazole.
Newman AH; Kulkarni S
Med Res Rev; 2002 Sep; 22(5):429-64. PubMed ID: 12210554
[TBL] [Abstract][Full Text] [Related]
37. Investigation of the potential pharmacokinetic and pharmaco-dynamic drug interaction between AHN 1-055, a potent benztropine analog used for cocaine abuse, and cocaine after dosing in rats using intracerebral microdialysis.
Raje S; Cornish J; Newman AH; Cao J; Katz JL; Eddington ND
Biopharm Drug Dispos; 2006 Jul; 27(5):229-40. PubMed ID: 16586462
[TBL] [Abstract][Full Text] [Related]
38. Dopamine/serotonin releasers as medications for stimulant addictions.
Rothman RB; Blough BE; Baumann MH
Prog Brain Res; 2008; 172():385-406. PubMed ID: 18772043
[TBL] [Abstract][Full Text] [Related]
39. Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers.
Carroll FI; Runyon SP; Abraham P; Navarro H; Kuhar MJ; Pollard GT; Howard JL
J Med Chem; 2004 Dec; 47(25):6401-9. PubMed ID: 15566309
[TBL] [Abstract][Full Text] [Related]
40. Elevated serotonin is involved in hyperactivity but not in the paradoxical effect of amphetamine in mice neonatally lesioned with 6-hydroxydopamine.
Avale ME; Nemirovsky SI; Raisman-Vozari R; Rubinstein M
J Neurosci Res; 2004 Oct; 78(2):289-96. PubMed ID: 15378510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
